2020
Quality and Publication of Emergency Medicine Trials Registered in ClinicalTrials.gov
Calvocoressi L, Reynolds J, Johnson B, Warzoha MM, Carroll M, Vaca FE, Post L, Dziura J. Quality and Publication of Emergency Medicine Trials Registered in ClinicalTrials.gov. Western Journal Of Emergency Medicine 2020, 21: 295-303. PMID: 32191186, PMCID: PMC7081876, DOI: 10.5811/westjem.2019.12.44096.Peer-Reviewed Original ResearchMeSH KeywordsClinical Trials as TopicEmergency MedicineHumansNational Institutes of Health (U.S.)PublicationsResearch DesignUnited StatesConceptsClinical trialsEM trialsKaplan-Meier curvesLog-rank testNational clinical trialClinical trial researchChi-square testEM studiesTrial qualityInterventional trialsPeer-reviewed journalsMedicine trialsNeurological conditionsLarger sample sizeTrial researchStudy characteristicsStudy periodTrialsNational InstituteSubspecialty areasBlindingPeriodic assessmentDescriptive statisticsHigher proportionIndustry funding
2007
Exogenous hormone use and meningioma risk
Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, Wrensch M. Exogenous hormone use and meningioma risk. Cancer 2007, 110: 471-476. PMID: 17580362, DOI: 10.1002/cncr.22783.Peer-Reviewed Original ResearchMeSH KeywordsClinical Trials as TopicContraceptives, Oral, HormonalEstrogen Replacement TherapyHumansMeningeal NeoplasmsMeningiomaRisk FactorsConceptsCase-control studyExogenous hormone useHormone replacement therapyMeningioma riskOral contraceptivesHormone useReplacement therapyHospital-based case-control studyPopulation-based case-control studyRandomized clinical trial dataTumor receptor subtypeRetrospective cohort studyCommon clinical questionsLarge national cohortRisk of meningiomaClinical trial dataEnglish-language literatureCohort studyNational cohortReceptor subtypesClinical questionsIntracranial meningiomasTrial dataFurther evaluationExogenous hormones